SAN DIEGO, Aug. 13, 2014 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (IMMY), a specialty pharmaceutical company dedicated to delivering high quality, novel, and customizable medicines to physicians and patients pursuant to prescriptions for individually identified patients at accessible prices, today announced selected financial results for the quarter ended June 30, 2014, and provided an ...
Business For Sale in Boston News Snippet brought to you by: BizLocal.com
BizLocal provides a Business For Sale Market Place and more.
A web-property of Inspetta LLC, providing innovative web, software and marketing services to business.
Call 800-785-2925 for more information.